Related Experiment Videos
[Dopexamine hydrochloride. A new synthetic sympathomimetic]
N A Pedersen1, L E Bang, P M Petersen
1Centralsygehuset i Naestved, medicinsk afdeling.
Ugeskrift for Laeger
|May 27, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Randomized trial of low-dose, ultrasound-assisted thrombolysis or heparin for pulmonary embolism.
Cardiovascular research·2026
Brain health trajectories 3 years after hospitalization for COVID-19, pneumonia, myocardial infarction, or critical illness.
Journal of the neurological sciences·2025
Risk factors of long-term brain health outcomes after hospitalization for critical illness.
Journal of neurology·2024
Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047).
Annals of oncology : official journal of the European Society for Medical Oncology·2024
Local bone loss in patients with anti-citrullinated peptide antibody and arthralgia, evaluated with high-resolution peripheral quantitative computed tomography.
Scandinavian journal of rheumatology·2017
Imaging response during therapy with radium-223 for castration-resistant prostate cancer with bone metastases-analysis of an international multicenter database.
Prostate cancer and prostatic diseases·2017
[Endovascular treatment of iliofemoral venous thrombosis].
Ugeskrift for laeger·2026
[Lateral epicondylitis].
Ugeskrift for laeger·2026
[Infiltrating basal cell carcinoma with perineural growth in a 15-year-old].
Ugeskrift for laeger·2026
[Group A streptococcal toxic shock syndrome with influenza A and parapneumonic effusion].
Ugeskrift for laeger·2026
[The significance of frailty in the assessment of polypharmacy and deprescribing].
Ugeskrift for laeger·2026
[Nutrition in the prevention and treatment of frailty in older adults].
Ugeskrift for laeger·2026
Development of Phenoxyacetic Acid Hybrids With COX-2 Inhibitory Activity as Potential Anti-Neuroinflammatory Agents.
Drug development research·2026